Case Studies in Lung Cancer: Test Your Skills

Access Course


Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface. Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.


This activity is intended for hematologist/oncologist specialists.


The goal of this activity is to provide clinicians with the latest data, concepts, and recommendations regarding the diagnosis, biomarker testing, evidence-based frontline treatment, and potential treatment-related adverse events of patients with advanced lung cancer.


Learning Objectives:

  • Select appropriate diagnostic and biomarker tests to guide treatment selection for a patient with advanced lung cancer.
  • Order an appropriate, evidence-based frontline treatment regimen for a patient with advanced lung cancer.
  • Provide patient education for potential treatment-related adverse events.


Approximate Time to Complete: 30 minutes


Credit Available: Mar. 18, 2020 - Mar. 18, 2021


Developed through a partnership between SITC and Medscape.




Additional Lung Cancer Resources for Clinicans from SITC:


sitc-cig-rgb.png"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)" (Published July 17, 2018)




View Guidelines Here.

View On-demand Webinar Here.

Accreditation Council for Continuing Medical Education and ABIM Maintenance of Certification
AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit: 1.00
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 1.00